Alzheimer's a key part of Eli Lilly's India specialty medicine push, says company's country head Winselow Tucker

Eli Lilly has introduced Lormalzi in India, a pioneering treatment for Alzheimer's that specifically targets amyloid plaques, a significant contributor to the condition. Unlike previous therapies that merely alleviate symptoms, this innovative medication aims to modify the disease itself.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/T78HK0t
via IFTTT